We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+11.74%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$4.04B
AUM Growth
-$339M
Cap. Flow
-$669M
Cap. Flow %
-16.54%
Top 10 Hldgs %
52.59%
Holding
160
New
36
Increased
28
Reduced
47
Closed
13

Top Buys

Rank Stock Value
1
FDX icon
FedEx
FDX
+$81.2M
2
B
Barrick Mining
B
+$77.2M
3
FCX icon
Freeport-McMoran
FCX
+$46.6M
4
OCFT
OneConnect Financial Technology
OCFT
+$27.7M
5
STLD icon
Steel Dynamics
STLD
+$25.4M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$139M
2
META icon
Meta Platforms (Facebook)
META
+$125M
3
BABA icon
Alibaba
BABA
+$110M
4
SWKS icon
Skyworks Solutions
SWKS
+$95.4M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$85.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 30.55%
2 Industrials 19.46%
3 Technology 17.7%
4 Communication Services 11.39%
5 Healthcare 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
76
Agios Pharmaceuticals
AGIO
$1.95B
$2.41M 0.06%
68,752
– –
MRUS
77
DELISTED
Merus
MRUS
$2.29M 0.06%
190,408
– –
CAH icon
78
Cardinal Health
CAH
$55.5B
$2.1M 0.05%
44,670
– –
MRSN
79
DELISTED
Mersana Therapeutics
MRSN
$2.06M 0.05%
4,436
– –
SGMO
80
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.06M 0.05%
218,336
-22,176
-9% -$240K
ADI icon
81
Analog Devices
ADI
$187B
$2M 0.05%
17,168
+6,448
+60% +$755K
ORCL icon
82
Oracle
ORCL
$435B
$1.91M 0.05%
31,996
+2,578
+9% +$146K
LIVN icon
83
LivaNova
LIVN
$4.21B
$1.88M 0.05%
41,603
-30,000
-42% -$1.45M
WVE icon
84
Wave Life Sciences
WVE
$1.2B
$1.75M 0.04%
206,384
+80,199
+64% +$879K
ORTX
85
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.69M 0.04%
41,198
+5,496
+15% +$284K
BCEL
86
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1.67M 0.04%
+119,751
New +$1.79M
DNTH icon
87
Dianthus Therapeutics
DNTH
$6.25B
$1.64M 0.04%
15,091
– –
BCRX icon
88
BioCryst Pharmaceuticals
BCRX
$2.51B
$1.59M 0.04%
462,402
– –
XLRN
89
DELISTED
Acceleron Pharma
XLRN
$1.56M 0.04%
13,872
-5,928
-30% -$590K
FPRX
90
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.54M 0.04%
327,414
– –
RCUS icon
91
Arcus Biosciences
RCUS
$3.66B
$1.49M 0.04%
87,058
– –
AAPL icon
92
Apple
AAPL
$4.5T
$1.48M 0.04%
12,788
-8,660
-40% -$945K
ADPT icon
93
Adaptive Biotechnologies
ADPT
$4.05B
$1.46M 0.04%
30,028
-18,862
-39% -$793K
CSCO icon
94
Cisco
CSCO
$483B
$1.41M 0.03%
35,700
– –
ROKU icon
95
Roku
ROKU
$22.5B
$1.4M 0.03%
7,398
– –
INBX
96
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.35M 0.03%
+75,000
New +$1.36M
OVID icon
97
Ovid Therapeutics
OVID
$489M
$1.34M 0.03%
233,413
-68,176
-23% -$456K
CTMX icon
98
CytomX Therapeutics
CTMX
$750M
$1.33M 0.03%
+200,224
New +$1.48M
MRNA icon
99
Moderna
MRNA
$23.9B
$1.31M 0.03%
18,528
-12,532
-40% -$874K
NTLA icon
100
Intellia Therapeutics
NTLA
$1.68B
$1.29M 0.03%
65,031
-18,706
-22% -$390K
2 3
4
5 6

Similar funds

EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
HBFP
Henderson Brothers Financial Partners Pittsburgh, Pennsylvania $395M AUM

Platinum Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, Platinum Investment Management held 160 positions worth $4.04B, down 7.7% from $4.38B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Platinum Investment Management withdrew a net $669M in Q3 2020, closing 13 positions and reducing 47 holdings. Its most notable exit was Baidu, an estimated $29.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, up from 28% a quarter earlier, followed by Industrials and Technology.

Against the trend, Platinum Investment Management opened a new position in OneConnect Financial Technology worth $27.2M.

  • Platinum Investment Management's largest Q3 2020 buy was OneConnect Financial Technology: 127,674 shares worth $27.2M.
  • Platinum Investment Management added most to FedEx in Q3 2020, an estimated $81.2M increase.
  • Platinum Investment Management's biggest Q3 2020 reduction was Intel, cutting an estimated $139M.
  • Platinum Investment Management fully exited Baidu in Q3 2020, selling an estimated $29.1M.
  • Platinum Investment Management's ten largest holdings make up 53% of its $4.04B portfolio in Q3 2020.
  • Platinum Investment Management opened 36 new positions and closed 13 in Q3 2020.
  • Platinum Investment Management's portfolio value fell 7.7% quarter-over-quarter to $4.04B.

Based on Platinum Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.